跳至主要内容
临床试验/NCT04018209
NCT04018209已完成不适用

Aquagenic Pruritus in Myeloproliferative Neoplasms

University Hospital, Brest11 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2019年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
170
试验地点
11
主要终点
Description of pruritus in patients with myeloproliferative neoplasms

研究概览

简要总结

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms.

Prospective work based on the distribution of a dedicated questionnaire.

详细描述

Patients with myeloproliferative neoplasms identified and followed in French Hospitals. Patients could be followed for polycythemia vera or essential thrombocythemia or primary myelofibrosis.

Distribution of the questionnaire to each patient with myeloproliferative neoplasm (treated or not) suffering from aquagenic pruritus.

Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with one of three non-chromosomal Philadelphia-positive myeloproliferative neoplasms: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
  • Suffering (or having suffered) from aquagenic pruritus.
  • No age limit, but major
  • Patient having formulated his non-opposition

排除标准

  • Patients with MPN with non-aquagenic pruritus,
  • Patients with another hematologic disease and aquagenic pruritus
  • Patients unable to complete the questionnaire.
  • Patients with physical or mental disabilities to formulate non-opposition
  • Refusal of participation

结局指标

主要结局

Description of pruritus in patients with myeloproliferative neoplasms

时间窗: at the time of questionnaire completion (Day 0)

Intensity of pruritus (visual analogic scale)

次要结局

  • Description of therapies used to treat pruritus(at the time of questionnaire completion (Day 0))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验